AstraZeneca vaccine linked with ‘spike’ in cases of rare disease that can paralyse victims

Scientists have drawn a link between the Oxford-AstraZeneca vaccine and a “spike” in cases of a rare disease that can leave its victims paralysed.

Three separate studies reported an increase in Guillain-Barré syndrome (GBS) shortly after the roll out of the AstraZeneca vaccine.

GBS is a potentially deadly condition in which a person’s immune system attacks their nerves and gradually paralyses victims from the feet upwards. While most patients recover, it can be life-threatening or permanently debilitating.

Two of the studies looked at rates of GBS in England and said there was an increase in cases “attributable to” the AstraZeneca vaccine, or that there was a probable “causal link”.

The Telegraph has spoken to several people who developed GBS after receiving the AstraZeneca vaccine, and have become severely disabled as a result.

On Friday, one of the victims spoke of his “anger” that he had the AstraZeneca jab without knowing that it posed such a risk.

Anthony Shingler said: “It feels like the side effects were either missed or ignored.”

Read full story (paywalled)

Source: The Telegraph, 8 December 2023

Related reading on the hub:

• Interview with Charlet Crichton, founder of UKCVFamily
• Adverse reactions to Covid-19 vaccination - are adverse reactions adequately understood and are patients affected provided for in your area?